. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: Am J Addict. 2019 Apr 16;28(4):270–276. doi: 10.1111/ajad.12884

Table 3.

Product Moment Correlations of Physical and Relapse Worries about Quitting Buprenorphine with Demographic Characteristics, Buprenorphine Use History, and Expected Correlates (n = 138).

	Withdrawal Fear	Relapse Fear

	r (p = )	r (p = )
Age	0.07 (.424)	0.20 (.019)
Gender (Male)	−0.12 (.156)	−0.04 (.638)
Non-Latino White	−0.14 (.101)	−0.14 (0.090)
Education (Years)	−0.04 (.615)	0.00 (.959)
Log (Weeks on Buprenorphine)	0.07 (.436)	−0.18 (.035)
Current Buprenorphine Dose	0.21 (.016)	0.25 (.004)
Self-Efficacy to Quit Buprenorphine	−0.39 (<.001)	−0.77 (<.001)
Withdrawal Severity	0.16 (.061)	0.11 (.212)
Impulsivity	0.07 (.406)	0.26 (.002)
DIS Physical discomfort Tolerance	−0.23 (.006)	−0.27 (.001)
DIS Physical discomfort Avoidance	0.38 (<.001)	0.39 (<.001)
DTS Total	−0.43 (<.001)	−0.49 (<.001)